U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288151) titled 'MDMA-Assisted Massed Exposure Therapy for PTSD' on Dec. 15.
Brief Summary: The goal of this clinical trial is to investigate the efficacy of 3,4-methylenedioxy-methamphetamine hydrochloride (MDMA) combined with Massed Prolonged Exposure (PE) therapy for the treatment of posttraumatic stress disorder (PTSD) in adult participants diagnosed with PTSD. This randomized, placebo-controlled trial will enroll 95 participants.
The main questions it aims to answer are:
* Does the combination of PE + MDMA lead to greater reduction in PTSD symptom severity from pre-treatment to one-month follow-up compared to PE + placebo?
* Does PE + MDMA i...